This inventor holds 1 USPTO granted patent. Top assignee: Kanaph Therapeutics Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Jakyung Yoo: Innovator in SHP2 Inhibition
Introduction
Jakyung Yoo is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for SHP2, a protein implicated in various diseases.
Latest Patents
Jakyung Yoo holds a patent for an SHP2 inhibitor and its use. The patent describes a pharmaceutical composition aimed at preventing or treating diseases related to SHP2. This invention has the potential to effectively address health issues associated with this protein.
Career Highlights
Jakyung Yoo is currently associated with Kanaph Therapeutics Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing therapeutic solutions that can improve patient outcomes.
Collaborations
Some of his coworkers include Miyeon Kim and Dohyun Park, who contribute to the collaborative efforts at Kanaph Therapeutics Inc. Their teamwork enhances the research and development processes within the company.
Conclusion
Jakyung Yoo's contributions to the field of SHP2 inhibition highlight his role as an important inventor in the pharmaceutical industry. His innovative work has the potential to lead to significant advancements in disease treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile